Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence

被引:457
作者
Kortlever, Roderik M.
Higgins, Paul J.
Bernards, Rene
机构
[1] Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands
[3] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA
关键词
CELLULAR SENESCENCE; CANCER PROGRESSION; HUMAN FIBROBLASTS; ONCOGENIC RAS; G(1) CONTROL; HUMAN-CELLS; CYCLIN D1; EXPRESSION; GROWTH; GENE;
D O I
10.1038/ncb1448
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
p53 limits the proliferation of primary diploid fibroblasts by inducing a state of growth arrest named replicative senescence - a process which protects against oncogenic transformation and requires integrity of the p53 tumour suppressor pathway(1-3). However, little is known about the downstream target genes of p53 in this growth-limiting response. Here, we report that suppression of the p53 target gene encoding plasminogen activator inhibitor-1 ( PAI-1) by RNA interference ( RNAi) leads to escape from replicative senescence both in primary mouse embryo fibroblasts and primary human BJ fibroblasts. PAI-1 knockdown results in sustained activation of the PI( 3) K-PKB-GSK3 beta pathway and nuclear retention of cyclin D1, consistent with a role for PAI-1 in regulating growth factor signalling. In agreement with this, we find that the PI( 3) K-PKB-GSK3 beta-cyclin D1 pathway is also causally involved in cellular senescence. Conversely, ectopic expression of PAI-1 in proliferating p53-deficient murine or human fibroblasts induces a phenotype displaying all the hallmarks of replicative senescence. Our data indicate that PAI-1 is not merely a marker of senescence, but is both necessary and sufficient for the induction of replicative senescence downstream of p53.
引用
收藏
页码:877 / U155
页数:13
相关论文
共 41 条
[1]   Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice [J].
Almholt, K ;
Lund, LR ;
Rygaard, J ;
Nielsen, BS ;
Dano, K ;
Romer, J ;
Johnsen, M .
INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (04) :525-532
[2]   The plasminogen activation system in tumor growth, invasion, and metastasis [J].
Andreasen, PA ;
Egelund, R ;
Petersen, HH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (01) :25-40
[3]   A large-scale RNAi screen in human cells identifies new components of the p53 pathway [J].
Berns, K ;
Hijmans, EM ;
Mullenders, J ;
Brummelkamp, TR ;
Velds, A ;
Heimerikx, M ;
Kerkhoven, RM ;
Madiredjo, M ;
Nijkamp, W ;
Weigelt, B ;
Agami, R ;
Ge, W ;
Cavet, G ;
Linsley, PS ;
Beijersbergen, RL ;
Bernards, R .
NATURE, 2004, 428 (6981) :431-437
[4]  
Bissell MJ, 1999, CANCER RES, V59, p1757S
[5]   Bypass of senescence after disruption of p21(CIP1/WAF1) gene in normal diploid human fibroblasts [J].
Brown, JP ;
Wei, WY ;
Sedivy, JM .
SCIENCE, 1997, 277 (5327) :831-834
[6]   Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[7]   Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells [J].
Chandrasekar, N ;
Mohanam, S ;
Gujrati, M ;
Olivero, WC ;
Dinh, DH ;
Rao, JS .
ONCOGENE, 2003, 22 (03) :392-400
[8]   Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis [J].
Chen, ZB ;
Trotman, LC ;
Shaffer, D ;
Lin, HK ;
Dotan, ZA ;
Niki, M ;
Koutcher, JA ;
Scher, HI ;
Ludwig, T ;
Gerald, W ;
Cordon-Cardo, C ;
Pandolfi, PP .
NATURE, 2005, 436 (7051) :725-730
[9]   Urokinase plasminogen activator system - A multifunction role in tumor progression and metastasis [J].
Choong, PFM ;
Nadesapillai, APW .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2003, (415) :S46-S58
[10]   INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN-MEDIATED BY PROTEIN-KINASE-B [J].
CROSS, DAE ;
ALESSI, DR ;
COHEN, P ;
ANDJELKOVICH, M ;
HEMMINGS, BA .
NATURE, 1995, 378 (6559) :785-789